Compare CSTL & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | BW |
|---|---|---|
| Founded | 2007 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Building Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.7M | 544.4M |
| IPO Year | 2019 | N/A |
| Metric | CSTL | BW |
|---|---|---|
| Price | $39.29 | $5.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $42.83 | $5.50 |
| AVG Volume (30 Days) | 370.2K | ★ 2.9M |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $343,530,000.00 | ★ $721,285,000.00 |
| Revenue This Year | $1.69 | N/A |
| Revenue Next Year | N/A | $4.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 10.15 | ★ 80.30 |
| 52 Week Low | $14.59 | $0.22 |
| 52 Week High | $42.18 | $7.77 |
| Indicator | CSTL | BW |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 50.83 |
| Support Level | $37.76 | $4.73 |
| Resistance Level | $42.18 | $5.44 |
| Average True Range (ATR) | 1.20 | 0.49 |
| MACD | -0.35 | -0.07 |
| Stochastic Oscillator | 46.17 | 48.20 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.